Article

Genomic Discovery of EF-24 Targets Unveils Antitumorigenic Mechanisms in Leukemia Cells

2024-10-16

Abstract excerpt

Curcumin, a polyphenolic compound derived from the plant Curcuma longa L., has demonstrated a wide range of therapeutic properties, including potential anticancer effects. However, its clinical efficacy is limited due to poor bioavailability and stability. To overcome these challenges, curcumin analogs like EF-24 have been developed with improved pharmacological properties. In this study, we used whole-transcript...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7949c98d-5f9b-59ea-997b-5784a87597ec
DOI: 10.1101/2024.10.14.618197

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomic Discovery of EF-24 Targets Unveils Antitumorigenic Mechanisms in Leukemia CellsDOI 10.1101/2024.10.14.618197Read

Novel flavagline‐like compounds with potent Fli‐1 inhibitory activity suppress diverse types of leukemiaSemantic proximity Read

Curcumin-Induced Molecular Mechanisms in U-87 MG Glioblastoma Cells: Insights from Global Gene Expression ProfilingSemantic proximity Read

Global Gene Expression Profiling Reveals Curcumin-Induced Molecular Mechanisms in U87 MG Glioblastoma CellsSemantic proximity Read

UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein responseSemantic proximity Read

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression dataSemantic proximity Read

Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemiaSemantic proximity Read

RNA-Sequencing Reveals Candidate Genes/Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic LeukemiaSemantic proximity Read

Targeting IL-1/IRAK1/4 signaling in Acute Myeloid Leukemia Stem Cells Following Treatment and RelapseSemantic proximity Read

[Transcription factor-based therapies for acute myeloid leukemia].Semantic proximity Read

Ellagic Acid and Cancer Hallmarks: Insights from Experimental EvidenceSemantic proximity Read

SLFN11 is a general target for enhancing the sensitivity of cancer to chemotherapy (DNA-damaging agents)Semantic proximity Read

Translation Initiation Represents an Acute Myeloid Leukemia Cell Vulnerability That Can Be Co-Targeted With BCL-2 InhibitionSemantic proximity Read